General MedicationsORALStandard
ARYNTA
LISDEXAMFETAMINE DIMESYLATE
Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ARYNTA is listed in Drugs@FDA under application 219847 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LISDEXAMFETAMINE DIMESYLATE Form and strength SOLUTION;ORAL - 10MG/ML Sponsor AZURITY Submission history Latest submission status date: 2025-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview ARYNTA is listed in Drugs@FDA under application 219847 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LISDEXAMFETAMINE DIMESYLATE Form and strength SOLUTION;ORAL - 10MG/ML Sponsor AZURITY Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.